Ki Cheong Park Selected Research

Neoplasm Metastasis (Metastasis)

11/2023	Discovery of New Anti-Cancer Agents against Patient-Derived Sorafenib-Resistant Papillary Thyroid Cancer.
1/2023	Olfactomedin 4 produces dysplasia but suppresses metastasis of colon cancer.
1/2022	Effects of Anti-Cancer Drug Sensitivity-Related Genetic Differences on Therapeutic Approaches in Refractory Papillary Thyroid Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ki Cheong Park Research Topics

Disease

22	Neoplasms (Cancer) 11/2023 - 02/2011
5	Thyroid Neoplasms (Thyroid Cancer) 11/2023 - 03/2017
5	Carcinogenesis 10/2018 - 02/2011
4	Papillary Thyroid Cancer 11/2023 - 10/2018
3	Neoplasm Metastasis (Metastasis) 11/2023 - 01/2022
3	Inflammation (Inflammations) 01/2023 - 04/2013
3	Carcinoma (Carcinomatosis) 09/2022 - 04/2013
3	Anaplastic Thyroid Carcinoma 01/2021 - 01/2017
2	Ulcerative Colitis 01/2023 - 04/2013
2	Colitis 02/2020 - 01/2018
2	Breast Neoplasms (Breast Cancer) 02/2019 - 02/2011
2	Renal Cell Carcinoma (Grawitz Tumor) 02/2019 - 01/2015
1	Colitis-Associated Neoplasms 01/2023
1	Colonic Neoplasms (Colon Cancer) 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 07/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 02/2020
1	Leukemia 02/2020
1	Stomach Neoplasms (Stomach Cancer) 08/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 09/2015
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2014
1	Neuroblastoma 12/2013
1	Colorectal Neoplasms (Colorectal Cancer) 04/2013
1	Adenoma (Adenomas) 04/2013
1	Fibrosarcoma 02/2011

Drug/Important Bio-Agent (IBA)

10	Sorafenib (BAY 43-9006)FDA Link 11/2023 - 01/2017
4	lenvatinibIBA 10/2020 - 01/2018
4	Histone Deacetylase InhibitorsIBA 03/2017 - 02/2011
3	Messenger RNA (mRNA)IBA 01/2023 - 04/2013
3	Histone Deacetylases (Histone Deacetylase)IBA 01/2018 - 02/2011
2	Paclitaxel (Taxol)FDA LinkGeneric 09/2022 - 02/2019
2	Cytochromes c (Cytochrome c)IBA 02/2019 - 01/2015
2	Tyrosine Kinase InhibitorsIBA 10/2018 - 01/2018
2	Deoxyglucose (2 Deoxy D glucose)IBA 01/2018 - 09/2015
2	Histones (Histone)IBA 03/2017 - 01/2015
2	Angiogenesis InhibitorsIBA 12/2013 - 02/2011
1	Glycoproteins (Glycoprotein)IBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Neutralizing AntibodiesIBA 01/2023
1	olfactomedinIBA 01/2023
1	Antineoplastic Agents (Antineoplastics)IBA 09/2022
1	prolinedithiocarbamate (PDTC)IBA 01/2022
1	CaspasesIBA 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2020
1	Dextrans (Dextran)FDA Link 02/2020
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 02/2020
1	Vascular Endothelial Growth Factor CIBA 08/2019
1	Caspase 3 (Caspase-3)IBA 02/2019
1	thiazolyl blueIBA 02/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2018
1	pregna-4,17-diene-3,16-dione (guggulsterone)IBA 01/2018
1	sym-trinitrobenzeneIBA 01/2018
1	Triggering Receptor Expressed on Myeloid Cells-1IBA 01/2018
1	Insulin-Like PeptidesIBA 01/2018
1	Calcium-Transporting ATPases (Ca2+ ATPase)IBA 01/2018
1	Phytosterols (Plant Sterols)IBA 01/2018
1	Sulfonic AcidsIBA 01/2018
1	ThapsigarginIBA 01/2018
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2018
1	Toll-Like Receptor 4IBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 09/2015
1	EndostatinsIBA 12/2013
1	Oxygen (Dioxygen)IBA 12/2013
1	terpestacinIBA 12/2013
1	Waste Products (Waste Product)IBA 12/2013
1	Proteins (Proteins, Gene)FDA Link 04/2013
1	Small Interfering RNA (siRNA)IBA 04/2013
1	Galectin 4 (LGALS4)IBA 04/2013
1	Vorinostat FDA Link 02/2011

Therapy/Procedure

8	Therapeutics 11/2023 - 02/2011
2	Radiotherapy 01/2021 - 02/2019